Assessment of Vision-related Quality of Life (VRQOL) in Cataract Patients During the COVID-19 Pandemic

Medical University Innsbruck1 site in 1 country116 target enrollmentSeptember 8, 2020

ConditionsSenile Cataract

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Senile Cataract
Sponsor: Medical University Innsbruck
Enrollment: 116
Locations: 1
Primary Endpoint: Improvement Vision-related quality of life
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.

Registry

clinicaltrials.gov

Start Date

September 8, 2020

End Date

March 2021

Last Updated

5 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Medical University Innsbruck

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Age ≥ 50 years
•Senile cataract
•Indication for unilateral or bilateral cataract surgery
•Postponed cataract surgery due to the COVID-19 pandemic
•Signed and dated declaration of consent

Exclusion Criteria

•Complex form of cataract (traumatic cataract, secondary cataract after intraocular inflammation)
•Amblyopia on the eye that is to be operated on
•Severe, visually impairing eye disease on the eye that is to operated on
•Known dementia or memory problems

Outcomes

Primary Outcomes

Improvement Vision-related quality of life

Time Frame: 3 months

Extent of improvement of vision-related qualitiy of life due to cataract surgery measured with the National Eye Institut Visual Function Questionnaire 25.